• In late February 2026, ACM Research reported fourth-quarter 2025 revenue of US$244.43 million and full-year revenue of US$901.31 million, alongside lower quarterly and annual net income compared with the prior year as earnings per share declined.
• A few days later, the company filed a US$135.27 million shelf registration for 2,624,473 Class A shares tied to an ESOP-related offering, highlighting how employee ownership and equity-based compensation sit alongside rising R&D and expansion costs that are weighing on margins.
• We’ll now examine how the margin compression highlighted in ACM Research’s latest results affects the existing investment narrative around its growth ambitions.

Find 47 companies with promising cash flow potential yet trading below their fair value.

ACM Research Investment Narrative Recap

To own ACM Research, you need to believe its specialty tools can translate rising semiconductor complexity into durable revenue while margin pressure remains manageable. The latest earnings showed higher sales but weaker profitability, and the new US$135.27 million ESOP-related shelf registration does not materially change the near term story: the key catalyst is execution on global expansion, while the biggest risk remains margin compression as costs rise faster than earnings.

The recent fourth quarter and full year 2025 results are central here, with revenue climbing to US$244.43 million in Q4 and US$901.31 million for the year, but net income and EPS declining. This widening gap between top line growth and bottom line performance directly connects to concerns about higher R&D, expansion spending and working capital strain, and it frames how investors may view upcoming product ramps and capacity additions as either an earnings opportunity or a margin risk.

Yet investors should also be aware that if margin pressure persists while ACM scales capacity to support up to US$3 billion of output and AI driven demand cools, then ...

ACM Research's narrative projects $1.4 billion revenue and $189.6 million earnings by 2028. This requires 19.1% yearly revenue growth and about a $77.5 million earnings increase from $112.1 million today.

Uncover how ACM Research's forecasts yield a $51.87 fair value, in line with its current price.

Exploring Other Perspectives

The most bearish analysts were already assuming only about US$1.5 billion of revenue and US$192 million of earnings by 2029, so if AI related wafer equipment demand or ACM’s expanded capacity fail to deliver as planned, their more cautious view could gain weight and you may see those expectations shift again as this new margin and capital raising information is digested.

Explore 2 other fair value estimates on ACM Research - why the stock might be worth just $51.26!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your ACM Research research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free ACM Research research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate ACM Research's overall financial health at a glance.

Ready For A Different Approach?

Our top stock finds are flying under the radar-for now. Get in early:

• We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Invest in the nuclear renaissance through our list of 85 elite nuclear energy infrastructure plays powering the global AI revolution.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 22 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.